{"id":386094,"date":"2021-11-16T00:00:00","date_gmt":"2021-11-16T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360gi0055-medtech-gastrointestinal-endoscopy-devices-market-insights-europe-2022\/"},"modified":"2026-04-18T11:06:27","modified_gmt":"2026-04-18T11:06:27","slug":"m360gi0055-medtech-gastrointestinal-endoscopy-devices-market-insights-europe-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360gi0055-medtech-gastrointestinal-endoscopy-devices-market-insights-europe-2022\/","title":{"rendered":"Gastrointestinal Endoscopy Devices | Market Insights | Europe | 2022"},"content":{"rendered":"<p>The\u00a0COVID-19\u00a0pandemic has\u00a0negatively impacted screening as well as therapeutic procedures in 2020 and the impact is expected to continue till\u00a02023\u00a0in the European\u00a0GI\u00a0endoscopy device market. Once the market stabilizes, however, it will expand moderately through 2030\u00a0driven by\u00a0increasing screening and hence increased detection rates, leading to higher device usage. Due to the saturation of this space, a lack of innovation in most device segments, and relatively low reimbursement for\u00a0GI\u00a0endoscopy can be seen across Europe. Introduction of novel devices in the capsule endoscope and Barrett&#8217;s esophagus ablation device markets will keep the market afloat.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for\u00a0GI\u00a0endoscopy devices in France, Germany, Italy, Spain, and the UK across an 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386094","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-gastrointestinal-endoscopy-devices","medtech-geography-europe","medtech-date-949"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386094\/revisions"}],"predecessor-version":[{"id":387603,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386094\/revisions\/387603"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}